Israel Englander Brickell Biotech, Inc. Transaction History

Millennium Management LLC

  • $199 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
N/A
-312 Reduced 1.47%
20,912 $14,000
Q4 2022

Feb 14, 2023
SELL
$1.71 - $2.08 $12,835 - $15,612
-7,506 Reduced 26.13%
21,224 $31,000
Q3 2022

Nov 14, 2022
BUY
$1.72 - $4.41 $49,415 - $126,699
28,730 New
28,730 $51,000

Others Institutions Holding BBI

# of Institutions
1
Shares Held
65K
Call Options Held
0
Put Options Held
0
View Full List

About Brickell Biotech, Inc.

BBI Quotes by TradingView
  • Ticker BBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,873,960
  • Market Cap $6.75M
  • Description
  • Brickell Biotech, Inc., a clinical-stage pharmaceutical company, engages in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. The company develops sofpironium bromide, which has completed Phase III clinical trials for the treatment of primary ...
More about BBI
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email